In high-risk MDS patients, MDSCs show high levels of active STAT3 and CCR2, and the STAT3-ARG1 pathway may be the significant signaling pathway regulating MDSC-mediated CD8+ T-cell immunosuppression [110]. This evidence concerns the gene CD8A and myelodysplastic syndrome.